Prescribing
The NHS Cheshire and Merseyside Area Prescribing Group (APG) and its subgroups provide a framework to coordinate the integration of safe, clinically effective and cost-effective medicines across Cheshire and Merseyside. Improved outcomes and an improved experience for patients are central to the decision-making process.
The APG is a professional group consisting of GPs, pharmacists, and other key healthcare professionals who are responsible for ensuring robust standards and governance for decision-making.
-
Policies
APG policy, APG terms of reference and more
-
APG subgroups
New medicines, Formulary and guidelines, Interface prescribing, Safety, and Antimicrobial guide
-
Patient group directions
Patient group directions (PGDs)
-
Forms and applications
New service developments, individual funding requests, and appeals process
-
Reports
APG approvals reports and more
Statements and patient information
-
Wegovy™ access in Cheshire and Merseyside
Wegovy® (Semaglutide) – a weight-management treatment – is currently only available to NHS patients via specialist Tier 3 or 4 weight management services
-
Valproate
New regulatory measures for oversight of prescribing to new patients and existing female patients
-
Update on ADHD medication shortage
Attention deficit hyperactivity disorder (ADHD) medication shortages affecting the UK
-
Treatment of indigestion with Proton Pump Inhibitors (PPIs)
Patient Information including lifestyle advice and advice for stopping or stepping down PPI treatment for indigestion
-
Topiramate (Topamax)
Introduction of new safety measures, including a Pregnancy Prevention Programme
-
NICE technology appraisals
National Institute for Health and Care Excellence (NICE) technology appraisal (TA) guidance
Contact
For medicines optimisation enquiries, please email: Mop-enquiries@cheshireandmerseyside.nhs.uk